vs
Karyopharm Therapeutics Inc.（KPTI）与RBB Bancorp（RBB）财务数据对比。点击上方公司名可切换其他公司
Karyopharm Therapeutics Inc.的季度营收约是RBB Bancorp的1.1倍（$34.1M vs $32.3M），RBB Bancorp净利率更高（31.5% vs -299.9%，领先331.4%），RBB Bancorp同比增速更快（12.6% vs 11.6%），过去两年RBB Bancorp的营收复合增速更高（7.0% vs 1.4%）
RBB银行控股公司是总部位于美国的金融控股集团，旗下核心主体为皇家商业银行，主要服务亚裔社群、中小微企业、不动产投资者及零售客户，提供商业信贷、储蓄存款、财富管理等多元金融服务，业务覆盖美国沿海核心都会区。
KPTI vs RBB — 直观对比
营收规模更大
KPTI
是对方的1.1倍
$32.3M
营收增速更快
RBB
高出1.0%
11.6%
净利率更高
RBB
高出331.4%
-299.9%
两年增速更快
RBB
近两年复合增速
1.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $34.1M | $32.3M |
| 净利润 | $-102.2M | $10.2M |
| 毛利率 | — | — |
| 营业利润率 | -52.4% | 39.5% |
| 净利率 | -299.9% | 31.5% |
| 营收同比 | 11.6% | 12.6% |
| 净利润同比 | -232.0% | 132.1% |
| 每股收益（稀释后） | $-7.02 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KPTIRBB
| Q4 25 | $34.1M | $32.3M | ||
| Q3 25 | $44.0M | $32.6M | ||
| Q2 25 | $37.9M | $35.8M | ||
| Q1 25 | $30.0M | $28.5M | ||
| Q4 24 | $30.5M | $28.7M | ||
| Q3 24 | $38.8M | $30.3M | ||
| Q2 24 | $42.8M | $27.5M | ||
| Q1 24 | $33.1M | $28.2M |
净利润KPTIRBB
| Q4 25 | $-102.2M | $10.2M | ||
| Q3 25 | $-33.1M | $10.1M | ||
| Q2 25 | $-37.3M | $9.3M | ||
| Q1 25 | $-23.5M | $2.3M | ||
| Q4 24 | $-30.8M | $4.4M | ||
| Q3 24 | $-32.1M | $7.0M | ||
| Q2 24 | $23.8M | $7.2M | ||
| Q1 24 | $-37.4M | $8.0M |
营业利润率KPTIRBB
| Q4 25 | -52.4% | 39.5% | ||
| Q3 25 | -34.6% | 40.7% | ||
| Q2 25 | -64.3% | 36.1% | ||
| Q1 25 | -110.8% | 11.2% | ||
| Q4 24 | -102.4% | 17.6% | ||
| Q3 24 | -67.8% | 31.6% | ||
| Q2 24 | -65.7% | 35.6% | ||
| Q1 24 | -101.9% | 39.9% |
净利率KPTIRBB
| Q4 25 | -299.9% | 31.5% | ||
| Q3 25 | -75.2% | 31.2% | ||
| Q2 25 | -98.2% | 26.1% | ||
| Q1 25 | -78.2% | 8.0% | ||
| Q4 24 | -100.8% | 15.3% | ||
| Q3 24 | -82.7% | 23.1% | ||
| Q2 24 | 55.6% | 26.4% | ||
| Q1 24 | -112.8% | 28.4% |
每股收益（稀释后）KPTIRBB
| Q4 25 | $-7.02 | $0.59 | ||
| Q3 25 | $-3.82 | $0.59 | ||
| Q2 25 | $-4.32 | $0.52 | ||
| Q1 25 | $-2.77 | $0.13 | ||
| Q4 24 | $-2.33 | $0.26 | ||
| Q3 24 | $-3.85 | $0.39 | ||
| Q2 24 | $-2.97 | $0.39 | ||
| Q1 24 | $-4.85 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $60.5M | $212.3M |
| 总债务越低越好 | — | $119.9M |
| 股东权益账面价值 | $-292.9M | $523.4M |
| 总资产 | $108.4M | $4.2B |
| 负债/权益比越低杠杆越低 | — | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资KPTIRBB
| Q4 25 | $60.5M | $212.3M | ||
| Q3 25 | $37.7M | $234.9M | ||
| Q2 25 | $38.7M | $191.9M | ||
| Q1 25 | $38.8M | $238.8M | ||
| Q4 24 | $62.5M | $257.7M | ||
| Q3 24 | $72.8M | $349.4M | ||
| Q2 24 | $84.8M | $252.8M | ||
| Q1 24 | $30.6M | — |
总债务KPTIRBB
| Q4 25 | — | $119.9M | ||
| Q3 25 | — | $119.8M | ||
| Q2 25 | — | $119.7M | ||
| Q1 25 | — | $119.6M | ||
| Q4 24 | — | $119.5M | ||
| Q3 24 | — | $119.4M | ||
| Q2 24 | — | $119.3M | ||
| Q1 24 | — | $119.2M |
股东权益KPTIRBB
| Q4 25 | $-292.9M | $523.4M | ||
| Q3 25 | $-269.3M | $514.3M | ||
| Q2 25 | $-238.9M | $517.7M | ||
| Q1 25 | $-205.9M | $510.3M | ||
| Q4 24 | $-186.0M | $507.9M | ||
| Q3 24 | $-159.6M | $509.7M | ||
| Q2 24 | $-132.1M | $511.3M | ||
| Q1 24 | $-169.0M | $514.0M |
总资产KPTIRBB
| Q4 25 | $108.4M | $4.2B | ||
| Q3 25 | $96.2M | $4.2B | ||
| Q2 25 | $104.9M | $4.1B | ||
| Q1 25 | $127.7M | $4.0B | ||
| Q4 24 | $164.4M | $4.0B | ||
| Q3 24 | $189.5M | $4.0B | ||
| Q2 24 | $214.0M | $3.9B | ||
| Q1 24 | $204.5M | $3.9B |
负债/权益比KPTIRBB
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | — | 0.23× | ||
| Q4 24 | — | 0.24× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-11.8M | $43.4M |
| 自由现金流经营现金流 - 资本支出 | — | $42.6M |
| 自由现金流率自由现金流/营收 | — | 131.8% |
| 资本支出强度资本支出/营收 | 0.0% | 2.5% |
| 现金转化率经营现金流/净利润 | — | 4.26× |
| 过去12个月自由现金流最近4个季度 | — | $73.5M |
8季度趋势，按日历期对齐
经营现金流KPTIRBB
| Q4 25 | $-11.8M | $43.4M | ||
| Q3 25 | $-5.9M | $2.1M | ||
| Q2 25 | $-18.7M | $21.7M | ||
| Q1 25 | $-39.0M | $7.8M | ||
| Q4 24 | $-25.8M | $58.5M | ||
| Q3 24 | $-19.5M | $24.5M | ||
| Q2 24 | $-38.5M | $11.7M | ||
| Q1 24 | $-43.7M | $4.8M |
自由现金流KPTIRBB
| Q4 25 | — | $42.6M | ||
| Q3 25 | — | $1.8M | ||
| Q2 25 | — | $21.6M | ||
| Q1 25 | — | $7.6M | ||
| Q4 24 | $-25.9M | $57.7M | ||
| Q3 24 | — | $24.2M | ||
| Q2 24 | — | $11.5M | ||
| Q1 24 | $-43.9M | $4.7M |
自由现金流率KPTIRBB
| Q4 25 | — | 131.8% | ||
| Q3 25 | — | 5.4% | ||
| Q2 25 | — | 60.2% | ||
| Q1 25 | — | 26.7% | ||
| Q4 24 | -84.7% | 201.0% | ||
| Q3 24 | — | 80.0% | ||
| Q2 24 | — | 42.0% | ||
| Q1 24 | -132.6% | 16.6% |
资本支出强度KPTIRBB
| Q4 25 | 0.0% | 2.5% | ||
| Q3 25 | 0.0% | 1.1% | ||
| Q2 25 | 0.0% | 0.3% | ||
| Q1 25 | 0.0% | 0.6% | ||
| Q4 24 | 0.2% | 2.7% | ||
| Q3 24 | 0.0% | 0.8% | ||
| Q2 24 | 0.0% | 0.5% | ||
| Q1 24 | 0.6% | 0.5% |
现金转化率KPTIRBB
| Q4 25 | — | 4.26× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 2.32× | ||
| Q1 25 | — | 3.39× | ||
| Q4 24 | — | 13.34× | ||
| Q3 24 | — | 3.50× | ||
| Q2 24 | -1.62× | 1.61× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KPTI
| Products | $32.1M | 94% |
| License And Other | $2.0M | 6% |
RBB
暂无分部数据
